10 Stocks That Are About To Explode
In this piece, we will take a look at ten stocks that are about to explode. The stock market has been quite tumultuous recently.
Xoma Royalty Corp (XOMA)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 7,593,303 | $322,715,378 | +194% | 8.25% |
| 2. | Woodline Partners Michael Rockefeller And Karl Kroeker | 1,114,363 | $47,360,428 | +75% | 0.15% |
| 3. | Newtyn Management Noah Levy And Eugene Dozortsev | 709,247 | $30,142,997 | 3.76% | |
| 4. | Opaleye Management James A. Silverman | 338,374 | $14,380,895 | +13% | 1.3% |
| 5. | Water Island Capital John Orrico | 242,000 | $10,285,000 | 0.96% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $25.05 | 100,000 | $2,505,000.00 | 102,000 | 2025-12-04 | Filing | |
| $25.39 | 2,000 | $50,780.00 | 7,045 | 2025-06-30 | Filing | |
| $24.70 | 2,000 | $49,400.00 | 5,045 | 2025-04-07 | Filing | |
| $25.60 | 5,243 | $134,220.80 | 10,000 | 2025-04-07 | Filing | |
| $25.56 | 3,346 | $85,523.76 | 4,757 | 2025-04-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.81 | 15 | $552.15 | 30,079 | 2025-09-22 | Filing | |
| $36.93 | 15 | $553.95 | 30,094 | 2025-09-22 | Filing | |
| $35.98 | 4,300 | $154,714.00 | 30,109 | 2025-09-22 | Filing | |
| $25.38 | 25,637 | $650,667.06 | 62,701 | 2025-05-20 | Filing | |
| $25.38 | 10,482 | $266,033.16 | 22,563 | 2025-05-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 1,697,167 | $72,129,599 | 0% | |
| 2. | 1,605,532 | $68,235,116 | 0% | |
| 3. | 691,971 | $29,408,769 | 0% | |
| 4. | 505,165 | $21,469,513 | 0% | |
| 5. | 245,321 | $10,429,395 | 0% |
News See All
10 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert. Mark Lampert is an American investor who founded BVF Partners Ltd. in 1993.
10 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we examined Mark Lampert’s investment philosophy and decades of experience in the biotechnology space.
10 Pharmaceutical Stocks to Buy According to Timothy Lynch's Stonepine Capital
In this article, we take a look at the 10 pharmaceutical stocks to buy according to Timothy Lynch's Stonepine Capital.
Hedge Fund Resource Center